Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders
Top Cited Papers
- 1 April 2000
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 118 (4) , 655-660
- https://doi.org/10.1016/s0016-5085(00)70134-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Interleukin-10 inhibits hepatic injury and tumor necrosis factor-α and interferon-γ mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized miceJournal of Hepatology, 1999
- Interleukin–10 Expression and Function in Experimental Murine Liver Inflammation and FibrosisHepatology, 1998
- Production and role of interleukin-10 in concanavalin A-induced hepatitis in miceHepatology, 1997
- Progressive Liver Injury in Chronic Hepatitis C Infection Correlates With Increased Intrahepatic Expression of Th1–Associated CytokinesHepatology, 1996
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1995
- Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts.Journal of Clinical Investigation, 1994
- Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: Definition of optimal conditions for specimen collection and clinical application in interferon-treated patientsHepatology, 1994
- Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 regionJournal of General Virology, 1993
- Hepatitis C virus infection in kidney transplant recipientsHepatology, 1993